From BioPolicyWiki
Revision as of 17:19, 27 July 2008 by Jamiedbrooks (Talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Region Europe
Population 4,752,735
GDP (millions USD) 391,498
National Policies
Eggs for assisted reproduction PROHIBITED
Eggs for research PROHIBITED
Inheritable genetic modification PROHIBITED
Preimplantation genetic diagnosis social uses prohibited
Reproductive cloning PROHIBITED
Research cloning PROHIBITED
Sex selection "social uses prohibited" is not in the list of possible values (?, PROHIBITED, regulated, Social uses prohibited, no policy) for this property.
International Agreements
1997 COE Biomedicine Convention RATIFIED
1998 COE Cloning Convention signed
2005 UN Cloning Vote no
2005 UNESCO Sports Doping Convention RATIFIED


Key laws and policies

Foundational values

"The purpose of this Act is to ensure that medical applications of biotechnology are utilised for the benefit of everyone in an inclusive society. This shall be done in accordance with the principles of respect for human dignity, human rights and personal integrity and without any discrimination on the basis of genetic constitution, on the basis of the ethical norms that form part of our Western cultural heritage." (Preamble to the Biotechnology Law)

Prohibited practices

The Biotechnology Law prohibits:

  • Social sex selection
  • Genetic modification of embryos
  • Donation of eggs or sperm
  • Research on fertilised eggs, human embryos and cell lines derived from fertilised eggs or human embryos
  • Reproductive cloning
  • Research cloning
  • Gene therapy on fetuses and embryos
  • Gene therapy that may involve genetic modification of gametes
  • Surrogacy[1][2][3]

Permitted and regulated practices

PGD is not illegal (in the special case of serious sex-linked hereditary diseases for which no treatment is available), but not used.[1]

Regulatory activities

The Biotechnology Law requires registration of research establishments, authorizes the Ministry of Health and Care Services to issue further regulations, and established the Norwegian Biotechnology Advisory Board. The Norwegian Board of Health supervises the medical use of biotechnology.


  1. 1.0 1.1 American Society for Reproductive Medicine, "IFFS Surveillance 07," Fertility and Sterility (Vol. 87. No. 4, Suppl. 1, April 2007)
  2. Dolores Dooley and Panagiota Dalla-Vorgia, Ethics of New Reproductive Technologies: Cases and Questions Berghahn Books (2003), p. 66
  3. Maja Kirilova Eriksson, Reproductive Freedom: In the Context of International Human Rights and Humanitarian Law, Martinus Nijhoff Publishers (1999), p. 208